NCT05674227 is a clinical trial of Robotic surgery in Lung Cancer, sponsored by Agenzia di Tutela della Salute della Città Metropolitana di Milano.

Who is sponsoring NCT05674227?

NCT05674227 is sponsored by Agenzia di Tutela della Salute della Città Metropolitana di Milano.

What drugs are being tested in NCT05674227?

Interventions in NCT05674227: Robotic surgery, Video-assisted thoracoscopy, Open surgery.

What condition does NCT05674227 study?

NCT05674227 studies Lung Cancer.

Is NCT05674227 still recruiting?

NCT05674227 is currently status unknown. Last updated 1 February 2023.

Last reviewed 2023-02-01 · How we verify

NCT05674227

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cost-effectiveness Evaluation of Robotic Surgery in the Removal of Lung Lesions in the ATS of Milan

Status unknown Last updated 1 February 2023

What this trial tests

trial testing Robotic surgery in Lung Cancer in 5,400 participants. Status unknown.

Timeline

1 March 2023

Primary endpoint
31 August 2023

30 September 2023

Quick facts

Lead sponsor	Agenzia di Tutela della Salute della Città Metropolitana di Milano
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	5,400
Start date	1 March 2023
Primary completion	31 August 2023
Estimated completion	30 September 2023

Drugs / interventions tested

Robotic surgery
Video-assisted thoracoscopy
Open surgery

Conditions studied

Lung Cancer — all drugs for Lung Cancer →

Sponsor

Agenzia di Tutela della Salute della Città Metropolitana di Milano

Who can join

18 and older, any sex, with Lung Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to compare cost-effectiveness of robotic surgery with open surgery and video-assisted thoracoscopy surgery (VATS) in adult patients, resident in the ATS of Milan area, operated for lung cancer. The main question it aims to answer is: • Is the robotic surgery cost-effective compared with thoracotomy and VATS in the surgical treatment of operable lung cancers in the adult population of the ATS of Milan? Researchers will compare robotic surgery with open and VAT surgery of operable lung cancer to see if robotic surgery performs better in terms of cost per year of life gained or in terms of cost per quality of life earned.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Robotic vs thoracoscopic vs open lobectomy and segmentectomy for lung cancer: a multicenter cohort study in the ATS of Milan.
Mazzali C, Buzzoni C, Grignani F, Incarbone MA, et al · · 2026 · PMID 42237053 · DOI 10.1007/s11701-026-03496-1

Verify or expand the search:

Other trials of Robotic surgery

Trials testing the same drug.

NCT05611840 — RCT on Robotic vs. Endo-laparoscopic Approach for Difficult Choledocholithiasis · NA · unknown
NCT05089513 — Uterus Transplantation by Robotics - Gothenburg III · NA · terminated
NCT04777565 — Study of a Minimally Invasive Cochlear Access for Cochlear Implantation Via a Robotic Procedure · NA · completed
NCT06814093 — Robotic Versus Laparoscopic Surgery for Middle and Low Rectal Cancer: a Target Trial Emulation · active not recruiting
NCT05961423 — Robotic vs Laparoscopic D3-D4 Lymphadenectomy for Colorectal Cancer · NA · unknown

Other recruiting trials for Lung Cancer

Currently open trials in the same condition.

NCT07295821 — Osimertinib Induction and Maintenance for Chemo-ineligible Stage III Unresectable EGFR+ NSCLC: Single-arm Study · Phase 2 · recruiting
NCT06909201 — Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigatin · Phase 1 · recruiting
NCT07524114 — Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception · recruiting
NCT07487064 — Galvanize Aliya® EX Pulsed Electric Field (PEF) Treat and Resect Study · NA · recruiting
NCT07146568 — Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hos · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05674227 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Agenzia di Tutela della Salute della Città Metropolitana di Milano
Last refreshed: 1 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05674227.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing